Liver Cancer News

Sutent® Not Effective for Advanced Liver Cancer (July 10, 2009)

In a Phase II clinical trial, patients with inoperable, advanced hepatocellular (liver) cancer did not benefit from treatment with the targeted therapy Sutent® (sunitinib). The results of this study were published in Lancet Oncology. Hepatocellular carcinoma... Continue Reading

Women with Hypothyroidism at Increased Risk of Liver Cancer (June 22, 2009)

Women with Hypothyroidism at Increased Risk of Liver Cancer Long-term hypothyroidism in women significantly increases the risk of developing hepatocellular carcinoma (liver cancer), according to the results of a study published in Hepatology.[1] The liver... Continue Reading

Incidence of Liver Cancer on the Rise (April 8, 2009)

The incidence of liver cancer in the United States tripled between 1975 and 2005, but survival rates are improving, according to the results of a study published in the Journal of Clinical Oncology. The liver is the largest organ in the body and is responsible... Continue Reading

TheraSphere® Shows Promise in Treatment of Liver Metastases (March 31, 2009)

Among patients with colorectal cancer that has spread to the liver, treatment of the liver with TheraSphere® (yttrium-90 glass microspheres) appears to provide sustained stabilization of disease. These results were published in the journal Cancer. Colorectal... Continue Reading

Treatment of Hepatocellular Carcinoma (March 18, 2009)

Overview The following is a general overview of the treatment of hepatocellular carcinoma, the most common type of primary liver cancer. Choice of treatment will depend on the extent and location of the cancer, the health of the liver, and the overall... Continue Reading

Liver Cancer Screening/Prevention (March 18, 2009)

Overview Information about the prevention of cancer and the science of screening appropriate individuals at high risk of developing cancer is gaining interest. Physicians and individuals alike recognize that the best ”treatment“ of cancer is preventing... Continue Reading

Liver Cancer Overview (March 18, 2009)

Overview The liver is the largest organ inside of the body. It is located on the right side of the abdomen behind the ribs. The liver has many important functions, including:[1] Removing harmful substances from the blood. Making bile that helps in... Continue Reading

Avastin® plus Tarceva® Shows Promise in Advanced Hepatocellular Carcinoma (February 3, 2009)

Avastin® plus Tarceva® Shows Promise in Advanced Hepatocellular Carcinoma According to the results of a Phase II clinical trial, the combination of two targeted therapies-Avastin® (bevacizumab) and Tarceva® (erlotinib)-has anticancer activity in patients... Continue Reading

Avastin® plus Tarceva® Shows Promise in Advanced Hepatocellular Carcinoma (February 3, 2009)

Nexavar® Effective for Hepatocellular Carcinoma in Asians (January 21, 2009)

Nexavar® Effective for Hepatocellular Carcinoma in Asians Researchers from 23 medical centers in Asia have reported that Nexavar® (sorafenib) is effective in patients with advanced hepatocellular carcinoma (liver cancer). The results of this study were... Continue Reading